Ullman Anders sold VRNA

October 7, 2025 · Form 4 insider transaction

Ullman Anders sold 72,000 shares of Verona Pharma Plc, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
72,000
Price
N/A
Total value
N/A
Role
SecurityOrdinary Shares
Transaction codeD: Disposition to the issuer
Transaction dateOctober 7, 2025
Filing dateOctober 8, 2025
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.; Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award ("RSU Award"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration.

View the original Form 4 on SEC EDGAR